1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
5. Turkey In-vitro
Fertilization Outlook
5.1. Market Size &
Forecast
5.1.1. By Value
5.2. Market Share &
Forecast
5.2.1. By Technique (ICSI IVF v/s Non-ICSI/Traditional IVF)
5.2.2.
By Reagent (Embryo Culture
Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media)
5.2.3.
By Instruments (Imaging
Systems, Sperm Separation Systems, Ovum Aspiration Pumps, Incubators,
Micromanipulator Systems, Cryo-systems, Others)
5.2.4.
By Infertility (Female v/s
Male)
5.2.5.
By Embryo (Frozen-Thawed
Embryo v/s Fresh Embryo)
5.2.6.
By Application (Fertility
Clinics, Hospitals, Others)
5.2.7.
By End User (Locals,
Expats, Medical Tourists)
5.2.8. By Region
5.2.9. By Company (2022)
5.3. Market Map
5.3.1. By Technique
5.3.2. By Reagent
5.3.3. By Instruments
5.3.4. By Infertility
5.3.5. By Embryo
5.3.6. By Application
5.3.7. By End User
5.3.8. By Region
6.
ICSI In-vitro Fertilization Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1.
By Reagent (Embryo Culture
Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media)
6.2.2.
By Instruments (Imaging
Systems, Sperm Separation Systems, Ovum Aspiration Pumps, Incubators,
Micromanipulator Systems, Cryo-systems, Others)
6.2.3.
By Infertility (Female v/s
Male)
6.2.4.
By Embryo (Frozen-Thawed
Embryo v/s Fresh Embryo)
6.2.5.
By Application (Fertility
Clinics, Hospitals, Others)
6.2.6.
By End User (Locals,
Expats, Medical Tourists)
7.
Non-ICSI/Traditional In-vitro Fertilization Market
Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1.
By Reagent (Embryo Culture
Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media)
7.2.2.
By Instruments (Imaging
Systems, Sperm Separation Systems, Ovum Aspiration Pumps, Incubators,
Micromanipulator Systems, Cryo-systems, Others)
7.2.3.
By Infertility (Female v/s
Male)
7.2.4.
By Embryo (Frozen-Thawed
Embryo v/s Fresh Embryo)
7.2.5.
By Application (Fertility
Clinics, Hospitals, Others)
7.2.6.
By End User (Locals,
Expats, Medical Tourists)
8. Market Dynamics
8.1. Drivers
8.2. Challenges
9. Market Trends &
Developments
10. Policy &
Regulatory Landscape
11. Turkey Economic
Profile
12. Turkey In-vitro
Fertilization: SWOT Analysis
13. Porter’s Five Forces
Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14. Pricing Analysis
15. Competitive
Landscape
15.1.
Business Overview
15.2.
Product Offerings
15.3.
Recent Developments
15.4.
Financials (As Reported)
15.5.
Key Personnel
15.6.
SWOT Analysis
15.6.1. Medical Park Group
15.6.2. Medipol University
Hospital
15.6.3. Hisar Hospital
Intercontinental
15.6.4. Liv Hospital
15.6.5. Antolia IVF and
Women’s Health Centre
15.6.6. Acibadem Hospitals
Group
15.6.7. Florence Nightingale
Hospital
15.6.8. American Hospital
15.6.9. Memorial Hospitals
Group
15.6.10.
Medicana International
15.6.11.
Koc University Hospital
Strategic Recommendations